Geographic patterns of carbapenem-resistant, multi-drug-resistant and difficult-to-treat Acinetobacter baumannii in the Asia-Pacific region: results from the Antimicrobial Testing Leadership and Surveillance (ATLAS) program, 2020

替加环素 鲍曼不动杆菌 肉汤微量稀释 粘菌素 美罗培南 抗菌剂 抗药性 头孢菌素 微生物学 抗生素 医学 抗生素耐药性 生物 最小抑制浓度 细菌 铜绿假单胞菌 遗传学
作者
Chih-Hao Chen,Pin-Han Wu,Min‐Chi Lu,Mao‐Wang Ho,Po‐Ren Hsueh
出处
期刊:International Journal of Antimicrobial Agents [Elsevier BV]
卷期号:61 (2): 106707-106707 被引量:18
标识
DOI:10.1016/j.ijantimicag.2022.106707
摘要

This study evaluated the in-vitro activity of multiple classes of antibiotics, including novel β-lactam combination agents, tigecycline and colistin, against carbapenem-resistant (CRAB), multi-drug-resistant (MDRAB) and difficult-to-treat (DTRAB) Acinetobacter baumannii. Minimum inhibitory concentrations (MICs) were determined using the broth microdilution method. Susceptibility profiles and the distribution of selected antimicrobials among countries were illustrated and examined based on the breakpoints of the Clinical and Laboratory Standards Institute, European Committee on Antimicrobial Susceptibility Testing and the US Food and Drug Administration. In total, 847 A. baumannii isolates were evaluated, and 692 isolates were characterized as CRAB, MDRAB or DTRAB. The prevalence of drug-resistant A. baumannii was >70.0% in South Korea, India and China, while the resistance rate of tigecycline was <5.5%. The MICs of meropenem and meropenem/vaborbactam for drug-resistant A. baumannii were equal (both MIC50 and MIC90 were 32 mg/L, range 0.25-32 mg/L). The overall resistance rate remained high for multiple classes of antibiotics, including penicillins, cephalosporins, carbapenems, quinolones and aminoglycosides (>84.0%, >96.0%, >98.0%, >88.0% and >87.0%, respectively), but not colistin or tigecycline (1.1% and 4.3%, respectively). China showed the lowest susceptibility to tigecycline for drug-resistant A. baumannii isolates compared with other countries. In conclusion, the resistance rate of drug-resistant A. baumannii remains high against multiple classes of antimicrobials. Colistin was the most potent agent, followed by tigecycline. The geographic pattern of tigecycline-resistant A. baumannii varied among countries. Therefore, continuous surveillance of A. baumannii resistance profiles in different regions is required.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
我是老大应助六六采纳,获得10
刚刚
1秒前
amyshine发布了新的文献求助10
2秒前
3秒前
順意完成签到,获得积分10
3秒前
3秒前
内卷带师发布了新的文献求助10
3秒前
Jackcaosky发布了新的文献求助10
6秒前
欣欣子发布了新的文献求助10
6秒前
qlq完成签到 ,获得积分10
7秒前
高的傲发布了新的文献求助10
7秒前
1499yqq发布了新的文献求助30
8秒前
汉皇高祖发布了新的文献求助10
9秒前
亚胺培南西司他丁钠完成签到,获得积分10
9秒前
嘻嘻完成签到,获得积分10
10秒前
10秒前
汉堡包应助QQ采纳,获得10
10秒前
11秒前
xdas完成签到,获得积分20
12秒前
无极微光应助科研通管家采纳,获得20
15秒前
15秒前
FashionBoy应助科研通管家采纳,获得10
15秒前
英俊的铭应助科研通管家采纳,获得10
15秒前
Ava应助科研通管家采纳,获得10
15秒前
英俊的铭应助科研通管家采纳,获得10
15秒前
我是老大应助科研通管家采纳,获得10
15秒前
科研通AI2S应助科研通管家采纳,获得10
15秒前
15秒前
大个应助科研通管家采纳,获得10
15秒前
乐乐应助科研通管家采纳,获得10
15秒前
lizishu应助科研通管家采纳,获得10
15秒前
silence完成签到,获得积分10
16秒前
NexusExplorer应助ray采纳,获得10
16秒前
fair应助怪胎采纳,获得10
18秒前
欣雪完成签到 ,获得积分10
19秒前
20秒前
cedar发布了新的文献求助20
21秒前
21秒前
22秒前
橙子完成签到 ,获得积分10
22秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
HANDBOOK OF CHEMISTRY AND PHYSICS 106th edition 1000
ASPEN Adult Nutrition Support Core Curriculum, Fourth Edition 1000
AnnualResearch andConsultation Report of Panorama survey and Investment strategy onChinaIndustry 1000
Continuing Syntax 1000
Signals, Systems, and Signal Processing 610
Decentring Leadership 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 物理 内科学 复合材料 催化作用 物理化学 光电子学 电极 细胞生物学 基因 无机化学
热门帖子
关注 科研通微信公众号,转发送积分 6276814
求助须知:如何正确求助?哪些是违规求助? 8096370
关于积分的说明 16925565
捐赠科研通 5346083
什么是DOI,文献DOI怎么找? 2842251
邀请新用户注册赠送积分活动 1819538
关于科研通互助平台的介绍 1676745